| Small-molecule inhibitors and biologics for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis. | 2024 | American Journal of Clinical Dermatology |
| Anti-TNF-α induced paradoxical psoriasis in patients with ankylosing spondylitis: a systematic review. | 2024 | Clinical and Experimental Rheumatology |
| Comparative efficacy of advanced therapies for achieving endoscopic outcomes in Crohn’s disease: a systematic review and network meta-analysis. | 2024 | Clinical Gastroenterology & Hepatology |
| Discontinuation of anti-tumour necrosis factor therapy in patients with perianal fistulizing Crohn’s disease: individual participant data meta-analysis of 309 patients from 12 studies. | 2024 | Journal of Crohn’s and Colitis |
| Infliximab for maintenance of medically-induced remission in Crohn’s disease. | 2024 | Cochrane Database of Systematic Reviews |
| Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis. | 2023 | BMC Opthalmology |
| Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis. | 2023 | BMC Gastroenterology |
| Systematic review and meta-analysis: loss of response and need for dose escalation of infliximab and adalimumab in ulcerative colitis. | 2023 | Inflammatory Bowel Diseases |
| Comparative speed of early symptomatic remission with advanced therapies for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2023 | American Journal of Gastroenterology |
| Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. | 2023 | Cochrane Database of Systematic Reviews |
| The comparative efficacy and safety of biologics and small molecules for treating patients with ulcerative colitis in Portugal: a systematic literature review and network meta-analysis. | 2023 | European Review for Medical and Pharmacological Sciences |
| Biosimilars for the treatment of psoriasis: a systematic review of clinical trials and observational studies. | 2023 | JAMA Dermatology |
| Network meta-analysis: efficacy and safety of treatments for fistulising Crohn’s disease. | 2023 | European Journal of Gastroenterology & Hepatology |
| Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis. | 2023 | BMJ Open Ophthalmology |
| Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology. | 2023 | Digestive and Liver Disease |
| Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis. | 2023 | BMC Ophthalmology |
| Therapeutic equivalence of biosimilar and reference biologic drugs in rheumatoid arthritis: a systematic review and meta-analysis. | 2023 | JAMA Network Open |
| Comparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn’s disease: a systematic review and meta-analysis. | 2023 | Annals of Gastroenterology |
| Comparative efficacy and safety of combination therapy with infliximab for Crohn's disease: a systematic review and network meta-analysis. | 2023 | International Journal of Colorectal Disease |
| Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis. | 2023 | International Journal of Clinical Pharmacy |
| Dose escalation patterns of advanced therapies in Crohn’s disease and ulcerative colitis: a systematic literature review. | 2023 | Advances in Therapy |
| Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn's disease: systematic review and network meta-analysis of randomized controlled trials. | 2023 | Inflammatory Bowel Diseases |
| Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review. | 2023 | Pediatric Rheumatology Online Journal |
| Systematic literature review of real-world evidence on dose escalation and treatment switching in ulcerative colitis. | 2023 | ClinicoEconomic and Outcomes Research |
| Gender-based differences in response to tumor necrosis factor inhibitor therapies for ulcerative colitis: individual participant data meta-analyses of clinical trials. | 2023 | Inflammatory Bowel Diseases |
| Systematic review and meta-analysis: loss of response and need for dose escalation of infliximab and adalimumab in ulcerative colitis. | 2022 | Inflammatory Bowel Disease |
| Infliximab in hidradenitis suppurativa: a systematic review and meta-analysis. | 2022 | Dermatologic Therapy |
| A systematic review on infliximab biosimilar SB2: from pre-clinical data to real-world evidence. | 2022 | Expert Opinion on Biological therapy |
| Infliximab as a second-line therapy for children with refractory Kawasaki disease: a systematic review and meta-analysis of randomized controlled trials. | 2022 | British Journal of Clinical Pharmacology |
| Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis. | 2022 | BMC Pregnancy and Childbirth |
| Risk of hospitalization for serious infection after initiation of ustekinumab or other biologics in patients with psoriasis or psoriatic arthritis. | 2022 | American College of Rheumatology |
| Biologic disease-modifying antirheumatic drugs for preventing radiographic progression in psoriatic arthritis: a systematic review and network meta-analysis. | 2022 | Pharmaceutics |
| Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: systematic review and meta-analysis. | 2022 | Frontiers in Pharmacology |
| Prediction of relapse after anti-tumor necrosis factor cessation in Crohn's disease: individual participant data meta-analysis of 1317 patients from 14 studies. | 2022 | Clinical Gastroenterology and Hepatology |
| Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: a systematic review and meta-analysis. | 2022 | World Journal of Clinical Cases |
| The effect of pregnancy and inflammatory bowel disease on the pharmacokinetics of drugs related to inflammatory bowel disease-A systematic literature review. | 2022 | Pharmaceutics |
| Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis. | 2022 | BMC Gastroenterology |
| Vasculitis induced by biological agents used in rheumatology practice: a systematic review. | 2022 | Archives of Rheumatology |
| Artesunate, imatinib, and infliximab in COVID-19: a rapid review and meta-analysis of current evidence. | 2022 | Immunity, Inflammation and Disease |
| Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials. | 2022 | Seminars in Arthritis and Rheumatism |
| Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. | 2022 | Cochrane Database of Systematic Reviews |
| Number needed to treat network meta-analysis to compare biologic drugs for moderate-to-severe psoriasis. | 2022 | Advances in Therapy |
| The risk of adverse effects of TNF-α inhibitors in patients with rheumatoid arthritis: a network meta-analysis. | 2022 | Frontiers in Immunology |
| A systematic review on biological therapies in juvenile idiopathic inflammatory myopathies: an evidence gap in precision medicine. | 2022 | Clinical and Experimental Rheumatology |
| Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2022 | The Lancet Gastroenterology & Hepatology |
| Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: a systematic review and an individual-patient data meta-analysis of randomized controlled trials. | 2022 | Gastroenterology |
| Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year. | 2022 | Journal of Dermatological Treatment |
| Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. | 2022 | Modern Rheumatology |
| Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis. | 2021 | Therapeutic Advances in Chronic Disease |
| Efficacy of infliximab in the treatment of Kawasaki disease: a systematic review and meta-analysis. | 2021 | Experimental and Therapeutic Medicine |
| Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. | 2021 | BMJ Gut |
| P014 postoperative recurrence in Crohn's disease patients treated with adalimumab versus infliximab: a systematic review and meta-analysis. | 2021 | American Journal of Gastroenterology |
| Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn’s disease: a systematic review and network meta-analysis. | 2021 | The Lancet Gastroenterology & Hepatology |
| Anti-drug antibody formation against biologic agents in inflammatory bowel disease: a systematic review and meta-analysis. | 2021 | BioDrugs |
| The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies. | 2021 | BMJ Gut |
| Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | 2021 | Medicine Open |
| Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. | 2021 | Future Medicine |
| Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis. | 2021 | Therapeutic Advances in Chronic Disease |
| Will the inducing and maintaining remission of non-biological agents and biological agents differ for Crohn's disease? The evidence from the network meta-analysis. | 2021 | Frontiers in Medicine |
| Dose adjustment of biologic treatments for moderate-to-severe plaque psoriasis in the real world: a systematic review. | 2021 | Dermatology and Therapy |
| The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: a meta-analysis. | 2021 | Saudi Journal of Gastroenterology |
| Efficacy and safety of anti-TNFα therapy for uveitis associated with juvenile idiopathic arthritis: a systematic review and meta-analysis. | 2021 | Rheumatology and Therapy |
| Biological therapy in rheumatoid vasculitis: a systematic review. | 2021 | Clinical Rheumatology |
| Comparative of the effectiveness and safety of biological agents, tofacitinib, and fecal microbiota transplantation in ulcerative colitis: systematic review and network meta-analysis. | 2021 | Immunological Investigations |
| Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. | 2021 | Cochrane Database of Systematic Reviews |
| Systematic review and network meta-analysis: comparative efficacy and safety of biosimilars, biologics and JAK1 inhibitors for active Crohn disease. | 2021 | Frontiers in Pharmacology |
| Network meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis. | 2021 | American Journal of Health-System Pharmacy |
| Adalimumab biosimilars in the treatment of rheumatoid arthritis: a systematic review of the evidence for biosimilarity. | 2021 | Rheumatology Therapy |
| Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis. | 2021 | European Review for Medical and Pharmacological Sciences |
| Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis. | 2021 | Expert Review of Clinical Immunology |
| Efficacy of infliximab in treatment-resistant depression: a systematic review and meta-analysis. | 2020 | Pharmacology Biochemistry and Behaviour |
| Comparable long-term outcomes of cyclosporine and infliximab in patients with steroid-refractory acute severe ulcerative colitis: a meta-analysis. | 2020 | Frontiers in Medicine |
| Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: a meta-analysis. | 2020 | Medicine Open |
| Drug survival of biologics in treating ankylosing spondylitis: a systematic review and meta-analysis of real-world evidence. | 2020 | BioDrugs |
| First- and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis. | 2020 | Clinical Gastroenterology and Hepatology |
| Fourteen small molecule and biological agents for psoriatic arthritis: a network meta-analysis of randomized controlled trials. | 2020 | Medicine Open |
| Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis. | 2020 | Journal of Dermatological Science |
| Efficacy of stekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. | 2020 | Current Medical Research and Opinion |
| Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. | 2020 | Cochrane Database of Systematic Reviews |
| Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis. | 2020 | RMD Open |
| Comparable long-term outcomes of cyclosporine and infliximab in patients with steroid-refractory acute severe ulcerative colitis: a meta-analysis. | 2020 | Frontiers in Medicine |
| Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: a systematic review and indirect comparison. | 2019 | Pharmacological Research |
| Infliximab clinically treating ulcerative colitis: a systematic review and meta-analysis. | 2019 | Pharmacological Research |
| Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: a systematic overview of meta-analyses. | 2019 | United European Gastroenterology Journal |
| Infliximab clinically treating ulcerative colitis: a systematic review and meta-analysis. | 2019 | Pharmacological Research |
| Anti-TNFα agents are the best choice in preventing postoperative Crohn’s disease: a meta-analysis. | 2019 | Digestive and Liver Disease |
| Comparison of adverse events of biologicals for treatment of juvenile idiopathic arthritis: a systematic review. | 2019 | Expert Opinion on Drug Safety |
| Efficacy and safety of systemic treatments in psoriatic arthritis: a systematic review, meta-analysis and GRADE evaluation. | 2019 | Journal of the European Academy of Dermatology and Venereology |
| Comparative efficacy of anti-TNF therapies for the prevention of postoperative recurrence of Crohn's disease: a systematic review and network meta-analysis of prospective trials. | 2019 | Journal of Clinical Gastroenterology |
| Efficacy and safety of infliximab in pediatric Crohn disease: a systematic review and meta-analysis. | 2019 | Canadian Journal of Hospital Pharmacy |
| Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis: a network meta-analysis. | 2019 | Journal of Pharmacological Sciences |
| Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. | 2019 | Journal of the European Academy of Dermatology and Venereology |
| Meta-analysis: the influence of preoperative infliximab use on postoperative complications of Crohn’s disease. | 2019 | Inflammatory Bowel Diseases |
| Effect of accelerated infliximab induction on short- and long-term outcomes of acute severe ulcerative colitis: a retrospective multicenter study and meta-analysis. | 2019 | Clinical Gastroenterology and Hepatology |
